You're reading the free version. Trader adds the live tape and alerts.
Start tracking
SYRE Sale Disclosure
Burrows Scott L · SEC Form 4 · Filed Jun 3, 2026
Sale
Calculated transaction value
$223.39K
Burrows Scott L Chief Financial Officer
SYRE
Spyre Therapeutics
SYRE
Transaction date
Jun 1, 2026
Public filing date
Jun 3, 2026
Filing lag
Filed 2 days later
SYRE daily price context
Close on/before transaction
$70.54
Jun 1, 2026
First close after public filing
$78.48
Jun 4, 2026
30-day return after filing
+13.07%
Through Jul 6, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 3,100 shares @ $72.06
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001636282-26-000076
Filing cohort
Transactions in this filing
Showing 5 of 5
Trades
5
Issuers
1
Estimated value
$641.69K
Buys / sales
0 / 3
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Spyre Therapeutics, Inc. SYRE | Exercise | Jun 1, 2026 | $108.75K |
| Spyre Therapeutics, Inc. SYRE | Sale | Jun 1, 2026 | $125.62K |
| Spyre Therapeutics, Inc. SYRE | Sale | Jun 1, 2026 | $183.93K |
| Spyre Therapeutics, Inc. SYRE Current | Sale | Jun 1, 2026 | $223.39K |
| Spyre Therapeutics, Inc. SYRE | Exercise | Jun 1, 2026 | $0 |